A correlation has been identified between elevated serum CEA levels prior to surgery and a diminished (OS), disease-free survival (DFS), and an elevated risk of mortality among patients with stage I–III colorectal cancer [38]. The gene discussed is CEACAM5; the disease is colorectal cancer.